Watchlist Price Alert

Taisho Pharmaceutical Co... (TAIPY)

PNK: TAIPY · Real-Time Price · USD

14.00

null (null%)

At close: Jul 12, 2024, 8:00 PM

Taisho Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	255.97B	265.05B	250.18B	223.81B	282.57B	219.97B	201.28B	172.14B
Short-Term Investments	200M	7.22B	4.02B	14.09B	75.9B	29.74B	-3.16B	34.32B
Long-Term Investments	163.22B	146.41B	164.3B	143.39B	127.79B	272.35B	323.17B	257.49B
Other Long-Term Assets	15.97B	21.03B	16.27B	20.37B	99.25B	34.46B	665M	36.21B
Receivables	51.92B	53.27B	51.18B	65.01B	71.13B	75.16B	69.45B	75.16B
Inventory	53.33B	44.89B	46.38B	43.37B	29.52B	26.84B	27.5B	26.64B
Other Current Assets	14.46B	8.44B	5.98B	9.34B	10.67B	10.43B	10.72B	11.42B
Total Current Assets	375.88B	378.86B	357.73B	355.62B	469.78B	362.15B	308.95B	319.67B
Property-Plant & Equipment	141.17B	119.29B	113.19B	112.56B	91.28B	93.72B	97.28B	98.95B
Goodwill & Intangibles	238.49B	213.06B	216.53B	209.98B	24.3B	31.12B	34.37B	38.86B
Total Long-Term Assets	565.61B	509.29B	519.19B	497.42B	352B	438.01B	462.27B	439.38B
Total Assets	941.49B	888.16B	876.92B	853.05B	821.78B	800.16B	771.22B	759.05B
Account Payables	17B	15.1B	14.67B	18.05B	18.81B	19.94B	23.33B	27.08B
Deferred Revenue	209M	246M	-1.59B	-1.81B	-429M	n/a	n/a	n/a
Short-Term Debt	1.79B	2.29B	1.59B	1.81B	429M	n/a	n/a	n/a
Other Current Liabilities	33.01B	25.79B	22.06B	25.44B	16.33B	17.49B	15.95B	17.07B
Total Current Liabilities	73.78B	62.28B	57.67B	66.46B	58.45B	60.32B	58.1B	66.65B
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	25.57B	28.76B	28.11B	27.95B	25.66B	31.03B	31.91B	32.94B
Total Long-Term Liabilities	58.37B	57.92B	60.85B	44.89B	39.19B	48.52B	48.04B	49.28B
Total Liabilities	132.15B	120.2B	118.52B	111.34B	97.65B	108.84B	106.14B	115.92B
Total Debt	2.59B	3.5B	2.59B	3.11B	453M	n/a	n/a	n/a
Common Stock	30B	30B	30B	30B	30B	30B	30B	30B
Retained Earnings	713.78B	702.98B	703.04B	699.41B	706.74B	666.92B	644.04B	623.25B
Comprehensive Income	63.85B	36.2B	31.91B	17.38B	29.95B	n/a	n/a	n/a
Shareholders Equity	786.57B	748.15B	729.5B	712.08B	712.97B	675.23B	649.94B	629.25B
Total Investments	163.42B	153.62B	168.32B	157.47B	203.69B	302.09B	320.01B	291.8B